Detect, Treat, Save - Driving a revolution in healthcare
Metfora’s innovative technology has the ability to detect serious and potentially fatal chronic diseases while they are still treatable, reducing patient mortality and improving quality of life.
The Metfora AI-based blood test is the diagnostic tool of the future, driving a shift in healthcare to early diagnosis and intervention, improving patient care and reducing unnecessary medical costs. The test analyzes circulating metabolites to detect disease-driven metabolic changes. AI is used to extract these patterns which we term “metabolic fingerprints”.
A blood draw is performed during the annual exam or in response to symptoms
Circulating metabolites in the blood are analyzed using HPLC and mass spectrometry
“Metabolic fingerprints” are identified using algorithms developed by machine learning